Active, Not Recruiting
Pilot Study of IC14 (Atibuclimab), an Anti-CD14 Monoclonal Antibody, to Treat STEMI
NCT06678074
- Conditions
- Cardiovascular Diseases, Heart Diseases, Infarction, +12 more
- Locations
-
- Washington University School of Medicine St Louis, Missouri, United States
- University of Virginia Charlottesville, Virginia, United States